217 related articles for article (PubMed ID: 10092013)
61. Improved reactivity of hepatitis C virus core protein epitopes in a conformational antigen-presenting system.
Buratti E; Di Michele M; Song P; Monti-Bragadin C; Scodeller EA; Baralle FE; Tisminetzky SG
Clin Diagn Lab Immunol; 1997 Mar; 4(2):117-21. PubMed ID: 9067642
[TBL] [Abstract][Full Text] [Related]
62. [Epitope mapping of antigenic determinants of hepatitis C virus proteins by phage display].
Rechkina EA; Denisova GF; Masalova OV; Lideman LF; Denisov DA; Lesnova EI; Ataullakhanov RI; Gur'ianova SV; Kushch AA
Mol Biol (Mosk); 2006; 40(2):357-68. PubMed ID: 16637277
[TBL] [Abstract][Full Text] [Related]
63. [Detection of antibodies to the nucleocapsid protein of Hepatitis C virus by immunoenzyme analysis using synthetic peptides of nucleocapsid N-terminal part].
Firsova TV; Alekseenkova TI; Shibnev VA; Froesner G; Semiletov IuA
Vopr Virusol; 2001; 46(2):21-4. PubMed ID: 11392965
[TBL] [Abstract][Full Text] [Related]
64. The broad assessment of HCV genotypes 1 and 3 antigenic targets reveals limited cross-reactivity with implications for vaccine design.
von Delft A; Humphreys IS; Brown A; Pfafferott K; Lucas M; Klenerman P; Lauer GM; Cox AL; Gaudieri S; Barnes E
Gut; 2016 Jan; 65(1):112-23. PubMed ID: 26092843
[TBL] [Abstract][Full Text] [Related]
65. Characterization and mapping of a B-cell immunogenic domain in hepatitis C virus E2 glycoprotein using a yeast peptide library.
Mink MA; Benichou S; Madaule P; Tiollais P; Prince AM; Inchauspe G
Virology; 1994 Apr; 200(1):246-55. PubMed ID: 7510436
[TBL] [Abstract][Full Text] [Related]
66. Influence of hepatitis C virus (HCV) genotypes on HCV recombinant immunoblot assay patterns.
Pawlotsky JM; Roudot-Thoraval F; Pellet C; Aumont P; Darthuy F; Remire J; Duval J; Dhumeaux D
J Clin Microbiol; 1995 May; 33(5):1357-9. PubMed ID: 7542272
[TBL] [Abstract][Full Text] [Related]
67. Antigenic regions within the hepatitis C virus envelope 1 and non-structural proteins: identification of an IgG3-restricted recognition site with the envelope 1 protein.
Sällberg M; Rudén U; Wahren B; Magnius LO
Clin Exp Immunol; 1993 Mar; 91(3):489-94. PubMed ID: 7680297
[TBL] [Abstract][Full Text] [Related]
68. The hypervariable region 1 protein of hepatitis C virus broadly reactive with sera of patients with chronic hepatitis C has a similar amino acid sequence with the consensus sequence.
Watanabe K; Yoshioka K; Ito H; Ishigami M; Takagi K; Utsunomiya S; Kobayashi M; Kishimoto H; Yano M; Kakumu S
Virology; 1999 Nov; 264(1):153-8. PubMed ID: 10544140
[TBL] [Abstract][Full Text] [Related]
69. Characterization of mimotopes mimicking an immunodominant conformational epitope on the hepatitis C virus NS3 helicase.
Jolivet-Reynaud C; Adida A; Michel S; Deléage G; Paranhos-Baccala G; Gonin V; Battail-Poirot N; Lacoux X; Rolland D
J Med Virol; 2004 Mar; 72(3):385-95. PubMed ID: 14748062
[TBL] [Abstract][Full Text] [Related]
70. Differences in HCV antibody patterns in haemodialysis patients infected with the same virus isolate.
de Oliveira JM; Rispeter K; Viazov S; Saback FL; Roggendorf M; Yoshida CF
J Med Virol; 2001 Apr; 63(4):265-70. PubMed ID: 11241456
[TBL] [Abstract][Full Text] [Related]
71. Murine antibodies against E2 and hypervariable region 1 cross-reactively capture hepatitis C virus.
Esumi M; Ahmed M; Zhou YH; Takahashi H; Shikata T
Virology; 1998 Nov; 251(1):158-64. PubMed ID: 9813211
[TBL] [Abstract][Full Text] [Related]
72. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection.
Enomoto N; Sakuma I; Asahina Y; Kurosaki M; Murakami T; Yamamoto C; Ogura Y; Izumi N; Marumo F; Sato C
N Engl J Med; 1996 Jan; 334(2):77-81. PubMed ID: 8531962
[TBL] [Abstract][Full Text] [Related]
73. Reactivity of synthetic peptides representing selected sections of hepatitis C virus core and envelope proteins with a panel of hepatitis C virus-seropositive human plasma.
Jackson P; Petrik J; Alexander GJ; Pearson G; Allain JP
J Med Virol; 1997 Jan; 51(1):67-79. PubMed ID: 8986952
[TBL] [Abstract][Full Text] [Related]
74. Comparative analysis of variation and selection in the HCV genome.
Patiño-Galindo JÁ; González-Candelas F
Infect Genet Evol; 2017 Apr; 49():104-110. PubMed ID: 28087495
[TBL] [Abstract][Full Text] [Related]
75. Linear B-cell epitopes of the NS3-NS4-NS5 proteins of the hepatitis C virus as modeled with synthetic peptides.
Khudyakov Yu E; Khudyakova NS; Jue DL; Lambert SB; Fang S; Fields HA
Virology; 1995 Jan; 206(1):666-72. PubMed ID: 7530398
[TBL] [Abstract][Full Text] [Related]
76. Sequence analysis of NS3 protease gene in clinical strains of hepatitis C virus.
Lodrini S; Bagaglio S; Canducci F; De Mitri MS; Andreone P; Loggi E; Lazzarin A; Clementi M; Morsica G
J Biol Regul Homeost Agents; 2003; 17(2):198-204. PubMed ID: 14518724
[TBL] [Abstract][Full Text] [Related]
77. Antibody responses against B-cell epitopes of the hypervariable region 1 of hepatitis C virus in self-limiting and chronic human hepatitis C followed-up using consensus peptides.
Isaguliants MG; Widell A; Zhang SM; Sidorchuk A; Levi M; Smirnov VD; Santantonio T; Diepolder HM; Pape GR; Nordenfelt E
J Med Virol; 2002 Feb; 66(2):204-17. PubMed ID: 11782929
[TBL] [Abstract][Full Text] [Related]
78. [Impact of the heterogenicity of amino acid sequence on the immunoreactivity of an antigenic epitopic complex localized within amino acids 1192-1456 of protein NS3 protein of hepatitis C virus].
Ulanova TI; Puzyrev VF; Burkov AN; Obriadina AP
Vopr Virusol; 2006; 51(1):28-30. PubMed ID: 16515039
[TBL] [Abstract][Full Text] [Related]
79. Strong HCV NS3/4a, NS4b, NS5a, NS5b-specific cellular immune responses induced in Rhesus macaques by a novel HCV genotype 1a/1b consensus DNA vaccine.
Latimer B; Toporovski R; Yan J; Pankhong P; Morrow MP; Khan AS; Sardesai NY; Welles SL; Jacobson JM; Weiner DB; Kutzler MA
Hum Vaccin Immunother; 2014; 10(8):2357-65. PubMed ID: 25424943
[TBL] [Abstract][Full Text] [Related]
80. Lymphoproliferative responses to hepatitis C virus core, E1, E2, and NS3 in patients with chronic hepatitis C infection treated with interferon alfa.
Leroux-Roels G; Esquivel CA; DeLeys R; Stuyver L; Elewaut A; Philippé J; Desombere I; Paradijs J; Maertens G
Hepatology; 1996 Jan; 23(1):8-16. PubMed ID: 8550052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
